Bortezomib administration examination for high sensitization renal transplantation candidates.
Phase of Trial: Phase IV
Latest Information Update: 25 Jan 2019
Price : $35 *
At a glance
- Drugs Bortezomib (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 17 Jan 2019 Status changed from recruiting to completed.
- 13 Jul 2015 Planned number of patients changed from 2 to 5 as reported by University Hospital Medical Information Network - Japan.
- 07 Feb 2014 New trial record